Oculis
consistent results with in optimize trials | Oculis
Company
Deck Type
Deck date
August 2023
Slide
25 of 33
Related slides by other companies
GH Research
Investor Presentation
March 2023
phase single dose efficacy | GH Research
GH Research
Investor Presentation
March 2023
phase efficacy | GH Research
GH Research
Investor Presentation
March 2023
and observed improved outcome in phase phase single dose | GH Research
BioAtla
Investor Presentation
August 2022
phase trial design for cab naked antibody | BioAtla
Other recent decks by Oculis
See all presentations (7 decks)
Investor Presentation
April 2024
Investor Presentation
July 2023
Investor Conference
June 2023
Results
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights